{Discussion}Roche stop supporting the 454 platform by mid-2016

[SDPA_Pet]

Hi, I am a graduate student and I have just heard Roche stop supporting the 454 pyrosequencing platform by 2016. Our university has to buy another Next-gen sequencing platform.

I was surprised. Does anyone know what happened? Two year ago, I think 454 pyrosequencing occupied >50% market. I don't think this is about business. Also, lots of publications use pyrosequencing

Are they gonna develop new sequencing technologies? Is pyrosequencing a technological dead end? Is Illumina a good choice?

Ben

[Bukowski]

Why is any technology killed off? It's been superseded - either on price or performance or both.

According to Genomeweb, Illumina had 66% of the market in 2012:

http://www.genomeweb.com/sequencing/sequence-survey-illumina-holds-two-thirds-sequencing-market-splits-desktop-share

Roche's share was 8% at this point.

I think you may have been a bit misled on their market penetration post PGM and post-MiSeq